Medicare Enrolled
Dr. Marat Reyzelman, M.D.
Clinical Neurophysiology Physician · Marietta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reyzelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reyzelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reyzelman
Dr. Marat Reyzelman is a clinical neurophysiology physician in Marietta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Reyzelman performed 17,322 Medicare services across 967 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reyzelman received a total of $20,160 from 81 pharmaceutical and/or device companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical neurophysiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reyzelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in GA
$20,160 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,322
Medicare services
Top 17% in GA for clinical neurophysiology physician
967
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~962 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
16,190 | $5 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
355 | $85 | $282 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $62 | $197 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
114 | $43 | $142 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
83 | $123 | $405 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
82 | $114 | $374 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
64 | $164 | $500 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
63 | $50 | $157 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
45 | $76 | $244 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
36 | $134 | $507 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
24 | $106 | $281 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
23 | $149 | $604 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
22 | $67 | $212 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $74 | $249 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
16 | $192 | $679 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,160
Total received (2018-2024)
Avg $2,880/year across 7 years
Top 29% in GA for clinical neurophysiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
690
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,705 (58.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,498 (37.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$956 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,593
2023
$1,635
2022
$1,325
2021
$2,033
2020
$1,167
2019
$2,755
2018
$2,652
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sarepta Therapeutics, Inc.
$7,498
ABBVIE INC.
$228
Celgene Corporation
$185
MDD US Operations, LLC
$165
PFIZER INC.
$110
ARGENX US, INC.
$100
EMD Serono, Inc.
$58
Sumitomo Pharma America, Inc.
$52
Amgen Inc.
$47
UCB, Inc.
$31
Otsuka America Pharmaceutical, Inc.
$29
Lundbeck LLC
$23
Lilly USA, LLC
$17
Grifols USA, LLC
$17
Octapharma USA, Inc.
$17
Novartis Pharmaceuticals Corporation
$16
Top 3 companies account for 92.1% of 2024 payments
All-time payments by company (2018-2024) ›
Sarepta Therapeutics, Inc.
$7,498
ABBVIE INC.
$808
Biohaven Pharmaceuticals, Inc.
$790
Novartis Pharmaceuticals Corporation
$585
Teva Pharmaceuticals USA, Inc.
$563
Amgen Inc.
$557
UCB, Inc.
$556
Supernus Pharmaceuticals, Inc.
$554
Biogen, Inc.
$436
Sunovion Pharmaceuticals Inc.
$410
Alexion Pharmaceuticals, Inc.
$385
ACADIA Pharmaceuticals Inc
$380
Celgene Corporation
$377
EMD Serono, Inc.
$351
PFIZER INC.
$309
GENZYME CORPORATION
$309
CSL Behring
$274
Allergan, Inc.
$270
Allergan Inc.
$256
Neurelis, Inc.
$253
AbbVie Inc.
$243
Lundbeck LLC
$218
Upsher-Smith Laboratories LLC
$207
Acorda Therapeutics, Inc
$204
ARGENX US, INC.
$193
GE Healthcare
$188
MDD US Operations, LLC
$165
GE HEALTHCARE
$163
Grifols USA, LLC
$159
US WorldMeds, LLC
$153
Greenwich Biosciences, Inc.
$152
Sumitomo Pharma America, Inc.
$124
Harmony Biosciences LLC
$121
Abbott Laboratories
$110
UPSHER-SMITH LABORATORIES LLC
$102
Biohaven Pharmaceutical Holding Company Ltd.
$85
EISAI INC.
$83
Horizon Therapeutics plc
$78
Bausch Health US, LLC
$77
AbbVie, Inc.
$77
Avanir Pharmaceuticals, Inc.
$75
Janssen Pharmaceuticals, Inc
$67
Lilly USA, LLC
$64
Adamas Pharmaceuticals, Inc.
$64
Promius Pharma LLC
$57
ASSERTIO THERAPEUTICS, Inc.
$57
E.R. Squibb & Sons, L.L.C.
$57
Neurocrine Biosciences, Inc.
$55
SK Life Science, Inc.
$52
Otsuka America Pharmaceutical, Inc.
$51
Medline Industries, Inc.
$49
BANNER LIFE SCIENCES, LLC
$48
Mallinckrodt LLC
$48
Octapharma USA, Inc.
$47
Amneal Pharmaceuticals LLC
$40
Impax Laboratories, Inc.
$39
ARBOR PHARMACEUTICALS, INC.
$27
Bayer HealthCare Pharmaceuticals Inc.
$26
Almatica Pharma LLC
$26
JAZZ PHARMACEUTICALS INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
Medtronic USA, Inc.
$24
AQUESTIVE THERAPEUTICS, INC.
$22
LivaNova USA, Inc.
$20
Boston Scientific Corporation
$20
Mallinckrodt Enterprises LLC
$20
Mylan Pharmaceuticals Inc.
$19
TG THERAPEUTICS, INC.
$19
BOSTON SCIENTIFIC CORPORATION
$19
Kyowa Kirin, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Genentech USA, Inc.
$17
Assertio Therapeutics, Inc.
$16
Eisai Inc.
$16
Cala Health, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
GE HealthCare
$14
Avion Pharmaceuticals
$13
Jazz Pharmaceuticals Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · Dysport · EMGALITY · Epidiolex · Fintepla · Fycompa · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · Hizentra · Horizant · Hyalomatrix Wound Device · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · Ocrevus · PANZYGA · PAXLOVID · POMPE - DISEASE · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RESTORE · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Skyclarys · Soliris · Solitaire · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XYREM · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Clinical neurophysiology physicians within 10 mi
5
Per 100K population
0.7
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reyzelman is a mixed practice specialist, with above-average Medicare volume (top 17% in GA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reyzelman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Reyzelman performed 16,190 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reyzelman receive payments from pharmaceutical companies?
Yes. Dr. Reyzelman received a total of $20,160 from 81 companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reyzelman's costs compare to other clinical neurophysiology physicians in Marietta?
Dr. Reyzelman's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reyzelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Neurophysiology Physicians in Marietta
Browse clinical neurophysiology physicians in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Clinical Neurophysiology Physicians in GA
Clinical neurophysiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Neurophysiology Physicians in GA
Which GA clinical neurophysiology physicians receive the most from drug and device companies.
By company
Sarepta Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Sarepta Therapeutics, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology